These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 135476)

  • 1. Heart volume and myocardial connective tissue during development and regression of thyroxine-induced cardiac hypertrophy in rats.
    Edgren J; von Knorring J; Lindy S; Turto H
    Acta Physiol Scand; 1976 Aug; 97(4):514-8. PubMed ID: 135476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of sodium houttuyfonate on myocardial hypertrophy in mice and rats.
    Gao JP; Chen CX; Wang Y; Lü J; Gu WL
    J Pharm Pharmacol; 2009 May; 61(5):677-83. PubMed ID: 19406008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thyroxine-induced cardiomegaly in rats of different age.
    Wachtlová M; Ostádal B; Mares V
    Physiol Bohemoslov; 1985; 34(5):385-94. PubMed ID: 2933754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study of the factors influencing cardiac growth. III. Digitoxin treatment and thyroxine-induced cardiac hypertrophy in the rat.
    Nosztray K; Szabó J; Takács IE; Szegi J
    Acta Biol Hung; 1986; 37(3-4):209-18. PubMed ID: 2450432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hydrogen sulfide endothelin-induced myocardial hypertrophy in rats and the mechanism involved.
    Yang F; Liu Z; Wang Y; Li Z; Yu H; Wang Q
    Cell Biochem Biophys; 2014 Dec; 70(3):1683-6. PubMed ID: 24980860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Dynamic biochemical, metrometric and histomorphological studies in isoproterenol-induced myocardial hypertrophy and its regression in rats].
    Prodanov K; Kolarova R; Tsakova L; Balutsov M
    Eksp Med Morfol; 1991; 30(1):26-30. PubMed ID: 1832104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study of the factors influencing cardiac growth. II. Digitoxin treatment and isoproterenol-induced cardiac hypertrophy in the rat.
    Szabó J; Nosztray K; Takács IE; Szegi J
    Acta Biol Hung; 1985; 36(3-4):305-12. PubMed ID: 2436403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo collagen turnover during development of thyroxine-induced left ventricular hypertrophy.
    Karim MA; Ferguson AG; Wakim BT; Samarel AM
    Am J Physiol; 1991 Feb; 260(2 Pt 1):C316-26. PubMed ID: 1825450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Morphologic findings during regression of heart hypertrophy].
    Frenzel H
    Z Kardiol; 1985; 74 Suppl 7():107-18. PubMed ID: 2936013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Norepinephrine-induced cardiac hypertrophy of the cat heart.
    Marino TA; Cassidy M; Marino DR; Carson NL; Houser S
    Anat Rec; 1991 Apr; 229(4):505-10. PubMed ID: 1828654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of cardiac hypertrophy on arterial and cardiopulmonary baroreflex control of renal sympathetic nerve activity in anaesthetized rats.
    Flanagan ET; Buckley MM; Aherne CM; Lainis F; Sattar M; Johns EJ
    Exp Physiol; 2008 Sep; 93(9):1058-64. PubMed ID: 18487313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Left ventricular compliance in the DOCA-salt model of hypertension in the rat. Effects of propranolol.
    Cheav SL; Delcayre C; Besnard JC; Paolaggi F; Mouas C; Swynghedauw B
    Arch Int Pharmacodyn Ther; 1991; 314():5-24. PubMed ID: 1840461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thyroxine-induced cardiomegaly: assessment of nucleic acid, protein content and myosin ATPase of rat heart.
    Szabó J; Nosztray K; Takács I; Szegi J
    Acta Physiol Acad Sci Hung; 1979; 54(1):69-79. PubMed ID: 94743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of oligomeric grape seed proanthocyanidins on isoproterenol-induced cardiac remodeling in rats].
    Zuo YM; Gao S; Cao JF; Liu XY; Yu HJ; Zhang Y
    Yao Xue Xue Bao; 2010 May; 45(5):565-70. PubMed ID: 20931756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Normal left ventricular diastolic compliance after regression of hypertrophy.
    Schraeger JA; Canby CA; Rongish BJ; Kawai M; Tomanek RJ
    J Cardiovasc Pharmacol; 1994 Mar; 23(3):349-57. PubMed ID: 7515976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and degradation of myocardial protein during the development and regression of thyroxine-induced cardiac hypertrophy in rats.
    Sanford CF; Griffin EE; Wildenthal K
    Circ Res; 1978 Nov; 43(5):688-94. PubMed ID: 152166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urotensin II accelerates cardiac fibrosis and hypertrophy of rats induced by isoproterenol.
    Zhang YG; Li YG; Liu BG; Wei RH; Wang DM; Tan XR; Bu DF; Pang YZ; Tang CS
    Acta Pharmacol Sin; 2007 Jan; 28(1):36-43. PubMed ID: 17184580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional changes in the right and left ventricle during development of cardiac hypertrophy and after its regression.
    Cihák R; Kolár F; Pelouch V; Procházka J; Ostádal B; Widimský J
    Cardiovasc Res; 1992 Sep; 26(9):845-50. PubMed ID: 1451161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myocardial Rac1 exhibits partial involvement in thyroxin-induced cardiomyocyte hypertrophy and its inhibition is not sufficient to improve cardiac dysfunction or contractile abnormalities in mouse papillary muscles.
    Elnakish MT; Moldovan L; Khan M; Hassanain HH; Janssen PM
    J Cardiovasc Pharmacol; 2013 Jun; 61(6):536-44. PubMed ID: 23429587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemodynamic and metabolic activities of propionyl-L-carnitine in rats with pressure-overload cardiac hypertrophy.
    Yang XP; Samaja M; English E; Benatti P; Tarantola M; Cardace G; Motterlini R; Micheletti R; Bianchi G
    J Cardiovasc Pharmacol; 1992 Jul; 20(1):88-98. PubMed ID: 1383636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.